| Table B.2a. Medicare beneficiary prevalence* for chronic conditions** using fee-for-service (FFS) claims, 2010–2019 | ||||||||||||||||||||||||||||||||||||||
| Prev = prevalence | ||||||||||||||||||||||||||||||||||||||
| Totals | 2019 numerator | 2019 | 2018 numerator | 2018 | 2017 numerator | 2017 | 2016 numerator | 2016 | 2015 numerator | 2015 | ||||||||||||||||||||||||||||
| Total denominator† | 31,860,990 | 32,184,841 | 32,483,529 | 32607998 | 32,179,757 | |||||||||||||||||||||||||||||||||
| Denominator — males only▲ | 14,448,754 | 45.30% | 14,557,985 | 45.20% | 14,663,165 | 45.10% | 14680123 | 45.00% | 14,465,415 | 45.00% | ||||||||||||||||||||||||||||
| Denominator — females only‡ | 17,412,231 | 54.70% | 17,626,850 | 54.80% | 17,820,358 | 54.90% | 17927869 | 55.00% | 17,714,337 | 55.00% | ||||||||||||||||||||||||||||
| 👇sort by | ||||||||||||||||||||||||||||||||||||||
| Chronic condition** | 2019 numerator# | 2019 Prev Rate | 2018 numerator# | 2018 Prev Rate | 2017 numerator# | 2017 Prev Rate | 2016 numerator# | 2016 Prev Rate | 2015 numerator# | 2015 Prev Rate | ||||||||||||||||||||||||||||
| Hypertension | 18,792,401 | 59.00% | 18,938,578 | 58.80% | 19,060,192 | 58.70% | 19105483 | 58.60% | 18,750,064 | 58.30% | ||||||||||||||||||||||||||||
| Hyperlipidemia | 15,925,681 | 50.00% | 15,787,069 | 49.10% | 15,686,586 | 48.30% | 15146099 | 46.40% | 15,216,792 | 47.30% | ||||||||||||||||||||||||||||
| Rheumatoid arthritis/Osteoarthritis | 11,209,201 | 35.20% | 11,152,441 | 34.70% | 11,108,321 | 34.20% | 10908057 | 33.50% | 10,342,805 | 32.10% | ||||||||||||||||||||||||||||
| Ischemic heart disease | 8,856,093 | 27.80% | 8,917,499 | 27.70% | 9,018,718 | 27.80% | 9122052 | 28.00% | 9,083,042 | 28.20% | ||||||||||||||||||||||||||||
| Diabetes | 8,771,622 | 27.50% | 8,919,842 | 27.70% | 9,081,954 | 28.00% | 9163634 | 28.10% | 9,062,604 | 28.20% | ||||||||||||||||||||||||||||
| Chronic kidney disease | 8,280,804 | 26.00% | 8,145,457 | 25.30% | 8,048,628 | 24.80% | 7531754 | 23.10% | 6,228,879 | 19.40% | ||||||||||||||||||||||||||||
| Anemia | 7,195,348 | 22.60% | 7,239,463 | 22.50% | 7,306,548 | 22.50% | 7324867 | 22.50% | 7,362,976 | 22.90% | ||||||||||||||||||||||||||||
| Depression | 6,172,840 | 19.40% | 6,066,669 | 18.80% | 5,966,519 | 18.40% | 5812110 | 17.80% | 5,741,768 | 17.80% | ||||||||||||||||||||||||||||
| Cataract | 5,614,119 | 17.60% | 5,685,874 | 17.70% | 5,787,577 | 17.80% | 5856642 | 18.00% | 5,834,323 | 18.10% | ||||||||||||||||||||||||||||
| Benign prostatic hyperplasia▲ | 2,604,982 | 18.00% | 2,513,186 | 17.30% | 2,466,882 | 16.80% | 2372143 | 16.20% | 2,241,647 | 15.50% | ||||||||||||||||||||||||||||
| Acquired hypothyroidism | 5,262,192 | 16.50% | 5,223,485 | 16.20% | 5,179,377 | 15.90% | 5154798 | 15.80% | 5,010,087 | 15.60% | ||||||||||||||||||||||||||||
| Heart failure | 4,657,176 | 14.60% | 4,655,713 | 14.50% | 4,665,730 | 14.40% | 4690896 | 14.40% | 4,652,637 | 14.50% | ||||||||||||||||||||||||||||
| Chronic obstructive pulmonary disease | 3,730,918 | 11.70% | 3,820,446 | 11.90% | 3,926,203 | 12.10% | 3927067 | 12.00% | 3,850,136 | 12.00% | ||||||||||||||||||||||||||||
| Alzheimer’s disease, related disorders, or senile dementia | 3,540,308 | 11.10% | 3,620,471 | 11.20% | 3,668,111 | 11.30% | 3625188 | 11.10% | 3,474,060 | 10.80% | ||||||||||||||||||||||||||||
| Glaucoma | 3,068,702 | 9.60% | 3,080,540 | 9.60% | 3,107,902 | 9.60% | 2392332 | 7.30% | 3,081,627 | 9.60% | ||||||||||||||||||||||||||||
| Atrial fibrillation | 2,805,567 | 8.80% | 2,806,009 | 8.70% | 2,811,985 | 8.70% | 2806954 | 8.60% | 2,789,063 | 8.70% | ||||||||||||||||||||||||||||
| Cancer, prostate▲ | 1,091,738 | 7.60% | 1,067,853 | 7.30% | 1,055,251 | 7.20% | 1041335 | 7.10% | 1,016,376 | 7.00% | ||||||||||||||||||||||||||||
| Osteoporosis | 2,291,912 | 7.20% | 2,190,226 | 6.80% | 2,137,230 | 6.60% | 2082581 | 6.40% | 2,066,638 | 6.40% | ||||||||||||||||||||||||||||
| Cancer, female breast‡ | 1,072,697 | 6.20% | 1,052,717 | 6.00% | 1,039,940 | 5.80% | 1023455 | 5.70% | 997,882 | 5.60% | ||||||||||||||||||||||||||||
| Asthma | 1,651,510 | 5.20% | 1,648,710 | 5.10% | 1,719,783 | 5.30% | 1726018 | 5.30% | 1,756,685 | 5.50% | ||||||||||||||||||||||||||||
| Alzheimer's disease | 1,255,744 | 3.90% | 1,322,474 | 4.10% | 1,385,665 | 4.30% | 1411457 | 4.30% | 1,385,135 | 4.30% | ||||||||||||||||||||||||||||
| Stroke/Transient ischemic attack | 1,238,014 | 3.90% | 1,256,114 | 3.90% | 1,270,729 | 3.90% | 1262036 | 3.90% | 1,270,383 | 3.90% | ||||||||||||||||||||||||||||
| Cancer, colorectal | 393,852 | 1.20% | 397,189 | 1.20% | 402,658 | 1.20% | 404897 | 1.20% | 406,155 | 1.30% | ||||||||||||||||||||||||||||
| Cancer, lung | 365,414 | 1.10% | 359,102 | 1.10% | 356,189 | 1.10% | 351744 | 1.10% | 348,239 | 1.10% | ||||||||||||||||||||||||||||
| Acute myocardial infarction | 304,933 | 1.00% | 306,038 | 1.00% | 308,640 | 1.00% | 300868 | 0.90% | 281,530 | 0.90% | ||||||||||||||||||||||||||||
| Cancer, endometrial‡ | 125,525 | 0.70% | 121,327 | 0.70% | 117,856 | 0.70% | 112644 | 0.60% | 105,032 | 0.60% | ||||||||||||||||||||||||||||
| Hip/Pelvic fracture | 235,452 | 0.70% | 236,967 | 0.70% | 239,523 | 0.70% | 234798 | 0.70% | 254,791 | 0.80% | ||||||||||||||||||||||||||||
| Cancer, male breast▲ | 9,027 | 0.10% | 8,863 | 0.10% | 8,801 | 0.10% | 8548 | 0.10% | 8,495 | 0.10% | ||||||||||||||||||||||||||||
| * Includes all Medicare beneficiaries who were eligible for or enrolled in Medicare on or after January 1, YYYY. The Chronic Conditions Warehouse (CCW) team calculates period prevalence for these rates: beneficiaries with full or nearly full FFS coverage during the year who had claim(s) for the condition within the condition-specified look back period (chronic conditions have a one- to three-year look-back period). Refer to the CCW website for more information, including the algorithms, for these CCW Condition Categories. | ||||||||||||||||||||||||||||||||||||||
| ** The CCW team may have counted beneficiaries in more than one chronic condition category. | ||||||||||||||||||||||||||||||||||||||
| † Denominator: Includes beneficiaries with full or nearly full FFS coverage (i.e., 11 or 12 months of Medicare Parts A and B [or coverage until time of death] and one month or less of health maintenance organization [HMO] coverage). | ||||||||||||||||||||||||||||||||||||||
| ‡ Denominator includes only females for cancer, endometrial and female breast. | ||||||||||||||||||||||||||||||||||||||
| ▲ Denominator includes only males for benign prostatic hyperplasia and cancer, prostate and cancer, male breast. # The CCW team defines the numerator as evidence of claims for the condition. | ||||||||||||||||||||||||||||||||||||||